With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

GSK had just two months to celebrate the positive phase 3 result with its checkpoint inhibitor Jemperli as a first-line therapy for endometrial cancer, before Merck & Co crashed the party.

GSK has participated in an impressive $175 million ... of the most elusive and high value genetically valued drivers of cancer." Other companies are also attempting to revisit fungi as a source ...

Join us for the kickoff of our Ang Lee retrospective with a 20th-anniversary, Valentine’s Day screening of the multiple-Academy Award-winning 'Brokeback Mountain'. Q&A w/ Ang Lee. Ang Lee's debut ...

The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.